July 16, 2019
As a physician-owned laboratory, we take seriously the responsibility of patient advocacy and our commitment to precision and excellence.
Our focus on gastrointestinal and gynecological pathology allows us to dedicate our resources to developing state-of-the-art technologies that enhance the quality of our service and positions us as the single best laboratory partner for our physician clients.
We live in an age where advancements in genetic testing make the dream of personalized medicine a reality. We looked at the most common conditions in GI and GYN and chose to build our test menu to provide the best screening tools for these conditions. Our test menu includes the most advanced techniques in histology, cytology, molecular and cytogenetics. Our talented scientific team continues to work on developing new innovative options that will enhance the screening for colon, esophageal, cervical and anal cancers.
In the fall of 2018, OmniPathology expanded its laboratory in Pasadena, California to 7200 square feet, creating a beautiful spacious work environment that emphasizes workflow within the lab and provides an atmosphere that inspires creativity.
With growth came the need to upgrade our quality systems. During the past 12 months, Omni took the initiative to rethink its procedures and policies with a strong focus on documentation practices, training and competency assessment. We participate in numerous proficiency testing programs, offered by the College of American Pathologists, to ensure that our testing accuracy, reliability and precision are independently measured. Furthermore, under the leadership of our medical director and quality assurance expert, we established the highest standards in new test validation and built confidence through comprehensive staff training to perform these new tests.
Over the years, Omni has created a best-in-class standardized diagnostic database. This clinically oriented standardized approach sets us apart from everyone else. Our pathologists are subspecialty trained and deeply committed to our new mission and vision.
March 1, 2017
OmniPathology Introduces State Of The Art FilmArray Technology for GI and Respiratory Pathogen PCR Testing
The FilmArray Gastrointestinal Panel from BioFire Diagnostics is FDA-cleared PCR testing technology and provides an overall sensitivity and specificity of 98.5% and 99.3%, respectively. Rapid and accurate diagnostic testing for gastrointestinal pathogens may help identify which patients to isolate or cohort faster and determine if antibiotic therapy is appropriate.
For more information, click here.